Literature DB >> 4601708

IgA nephropathy.

R C McCoy, C R Abramowsky, C C Tisher.   

Abstract

From a series of 470 specimens of renal tissue examined by immunofluorescence microscopy, 20 specimens were identified and studied in detail from patients without evidence of systemic disease in which IgA was the predominant localizing immunoglobulin. All patients presented with hematuria which was recurrent or persistent, often being exacerbated by upper respiratory infection. Most of the group pursued a benign clinical course with little evidence of decline in renal function. Histopathologic changes in renal biopsy specimens of most of the group consisted of a proliferative glomerulonephritis of variable intensity. Characteristic alterations were seen by electron microscopy which included the presence of electron-dense deposits within the mesangium, the hilar regions of the glomerulus and the basement membrane of Bowman's capsule. Evidence for activation of complement by the alternate pathway at C3 was found with properdin localization in 14 of 15 specimens and with the absence of detectable Clq and C4 in 15 specimens studied for these early acting components. It is concluded that the combined clinical, morphologic and immunologic findings warrant consideration of IgA nephropathy as a distinct clinicopathologic entity.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4601708      PMCID: PMC1910747     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  11 in total

1.  Superiority of fluorescein isothiocyanate (Riggs) for fluorescent-antibody technic with a modification of its application.

Authors:  J D MARSHALL; W C EVELAND; C W SMITH
Journal:  Proc Soc Exp Biol Med       Date:  1958 Aug-Sep

2.  Recurrent macroscopic hematuria, focal nephritis, and mesangial deposition of immunoglobulin and complement.

Authors:  L P Roy; A J Fish; R L Vernier; A F Michael
Journal:  J Pediatr       Date:  1973-05       Impact factor: 4.406

3.  Properties of highly purified human properdin.

Authors:  J Ensky; C F Hinz; E W Todd; R J Wedgwood; J T Boyer; I H Lepow
Journal:  J Immunol       Date:  1968-01       Impact factor: 5.422

4.  Glomerular and dermal depostion of properdin in systemic lupus erythematosus.

Authors:  N Rothfield; H A Ross; J O Minta; I H Lepow
Journal:  N Engl J Med       Date:  1972-10-05       Impact factor: 91.245

5.  [Intercapillary deposits of IgA-IgG].

Authors:  J Berger; N Hinglais
Journal:  J Urol Nephrol (Paris)       Date:  1968-09

6.  Immunoglobulin A (IgA) associated glomerulonephritis.

Authors:  D C Lowance; J D Mullins; J J McPhaul
Journal:  Kidney Int       Date:  1973-03       Impact factor: 10.612

7.  Glomerular deposition of properdin in acute and chronic glomerulonephritis with hypocomplementemia.

Authors:  N G Westberg; G B Naff; J T Boyer; A F Michael
Journal:  J Clin Invest       Date:  1971-03       Impact factor: 14.808

8.  Glomerular morphology, natural history and treatment of children with IgA-IgG mesangial nephropathy.

Authors:  P T McEnery; A J McAdams; C D West
Journal:  Perspect Nephrol Hypertens       Date:  1973

9.  C3 proactivator convertase and its mode of action.

Authors:  H J Müller-Eberhard; O Götze
Journal:  J Exp Med       Date:  1972-04-01       Impact factor: 14.307

10.  The human secretory immunoglobulin system: immunohistoligical localization of gamma A, secretory "piece," and lactoferrin in normal human tissues.

Authors:  D R Tourville; R H Adler; J Bienenstock; T B Tomasi
Journal:  J Exp Med       Date:  1969-02-01       Impact factor: 14.307

View more
  50 in total

1.  Isolated glomerulonephritis with mesangial IgA deposits.

Authors:  J G Sissons; D F Woodrow; J R Curtis; D J Evans; P E Gower; J C Sloper; D K Peters
Journal:  Br Med J       Date:  1975-09-13

2.  Direct immunofluorescent studies of urinary casts in human nephropathies.

Authors:  C Orfila; J Rakotoarivony; J M Suc
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1979

3.  Long-term follow up of renal function in IgA nephropathy.

Authors:  U B Berg
Journal:  Arch Dis Child       Date:  1991-05       Impact factor: 3.791

4.  IgA-nephropathy (IgA-IgG-nephropathy/IgA-nephritis)--a disease entity?

Authors:  H V Gärtner; F Hönlein; U Traub; A Bohle
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1979-12

5.  IgA nephropathy in adults: immunohistologic findings and clinical course.

Authors:  S K Parai; T Ghose
Journal:  Can Med Assoc J       Date:  1985-06-15       Impact factor: 8.262

6.  [Alcohol and IgA in the kidney].

Authors:  H Köhler
Journal:  Klin Wochenschr       Date:  1985-09-16

7.  Urinary IgA in IgA nephropathy and Henoch-Schoenlein purpura.

Authors:  J H Galla; M F Spotswood; L A Harrison; J Mestecky
Journal:  J Clin Immunol       Date:  1985-09       Impact factor: 8.317

8.  Mesangial C3 deposition and serum C3 levels predict renal outcome in IgA nephropathy.

Authors:  Dan Wu; Xueqian Li; Xingfeng Yao; Nan Zhang; Lei Lei; Hejia Zhang; Mengmeng Tang; Jie Ni; Chen Ling; Zhi Chen; Xiangmei Chen; Xiaorong Liu
Journal:  Clin Exp Nephrol       Date:  2021-02-23       Impact factor: 2.801

9.  The secretory immune system and renal disease.

Authors:  R S Dobrin; F E Knudson; A F Michael
Journal:  Clin Exp Immunol       Date:  1975-08       Impact factor: 4.330

10.  IgA glomerulonephritis. Mesangial IgA deposition without systemic signs (Berger's disease).

Authors:  J Nagy; H Brasch; T Süle; A Hámori; G Deák; M Ambrus
Journal:  Int Urol Nephrol       Date:  1979       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.